L'Occitane International S.A. (0973.HK)
HKD 33.8
(0.3%)
HKD 33.8
(0.3%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 2.01 Billion EUR | 17.35% |
| 2022 | 1.71 Billion EUR | 17.41% |
| 2021 | 1.46 Billion EUR | 14.59% |
| 2020 | 1.27 Billion EUR | -4.78% |
| 2019 | 1.34 Billion EUR | 13.0% |
| 2018 | 1.18 Billion EUR | 8.06% |
| 2017 | 1.09 Billion EUR | -0.37% |
| 2016 | 1.1 Billion EUR | 3.85% |
| 2015 | 1.06 Billion EUR | 10.2% |
| 2014 | 963.21 Million EUR | 12.58% |
| 2013 | 855.59 Million EUR | 0.02% |
| 2012 | 855.46 Million EUR | 13.23% |
| 2011 | 755.48 Million EUR | 18.61% |
| 2010 | 636.96 Million EUR | 28.09% |
| 2009 | 497.26 Million EUR | 15.16% |
| 2008 | 431.78 Million EUR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 Q4 | 588.19 Million EUR | 0.0% |
| 2023 Q1 | 419.95 Million EUR | -15.66% |
| 2023 Q2 | 419.95 Million EUR | 0.0% |
| 2023 FY | 2.01 Billion EUR | 17.35% |
| 2023 Q3 | 588.19 Million EUR | 40.06% |
| 2022 Q3 | 497.93 Million EUR | 37.88% |
| 2022 Q2 | 361.13 Million EUR | 0.0% |
| 2022 FY | 1.71 Billion EUR | 17.41% |
| 2022 Q1 | 361.13 Million EUR | -20.5% |
| 2022 Q4 | 497.93 Million EUR | 0.0% |
| 2021 Q3 | 454.26 Million EUR | 63.73% |
| 2021 Q1 | 277.44 Million EUR | -28.02% |
| 2021 Q2 | 277.44 Million EUR | 0.0% |
| 2021 Q4 | 454.26 Million EUR | 0.0% |
| 2021 FY | 1.46 Billion EUR | 14.59% |
| 2020 FY | 1.27 Billion EUR | -4.78% |
| 2020 Q1 | 253.11 Million EUR | -32.6% |
| 2020 Q2 | 253.11 Million EUR | 0.0% |
| 2020 Q3 | 385.45 Million EUR | 52.28% |
| 2020 Q4 | 385.45 Million EUR | 0.0% |
| 2019 Q3 | 375.56 Million EUR | 27.28% |
| 2019 FY | 1.34 Billion EUR | 13.0% |
| 2019 Q4 | 375.56 Million EUR | 0.0% |
| 2019 Q2 | 295.05 Million EUR | 0.0% |
| 2019 Q1 | 295.05 Million EUR | -15.27% |
| 2018 FY | 1.18 Billion EUR | 8.06% |
| 2018 Q4 | 348.22 Million EUR | 0.0% |
| 2018 Q3 | 348.22 Million EUR | 41.98% |
| 2018 Q1 | 245.26 Million EUR | -23.88% |
| 2018 Q2 | 245.26 Million EUR | 0.0% |
| 2017 Q2 | 226.97 Million EUR | 0.0% |
| 2017 FY | 1.09 Billion EUR | -0.37% |
| 2017 Q3 | 322.22 Million EUR | 41.97% |
| 2017 Q4 | 322.22 Million EUR | 0.0% |
| 2017 Q1 | 226.97 Million EUR | -30.05% |
| 2016 Q4 | 324.49 Million EUR | 0.0% |
| 2016 Q3 | 324.49 Million EUR | 43.13% |
| 2016 Q2 | 226.71 Million EUR | 0.0% |
| 2016 Q1 | 226.71 Million EUR | -26.34% |
| 2016 FY | 1.1 Billion EUR | 3.85% |
| 2015 Q4 | 307.78 Million EUR | 0.0% |
| 2015 FY | 1.06 Billion EUR | 10.2% |
| 2015 Q1 | 222.97 Million EUR | -22.2% |
| 2015 Q2 | 222.97 Million EUR | 0.0% |
| 2015 Q3 | 307.78 Million EUR | 38.04% |
| 2014 Q2 | 195.01 Million EUR | 0.0% |
| 2014 FY | 963.21 Million EUR | 12.58% |
| 2014 Q4 | 286.59 Million EUR | 0.0% |
| 2014 Q1 | 195.01 Million EUR | -20.9% |
| 2014 Q3 | 286.59 Million EUR | 46.96% |
| 2013 FY | 855.59 Million EUR | 0.02% |
| 2013 Q1 | 181.26 Million EUR | -25.51% |
| 2013 Q2 | 181.26 Million EUR | 0.0% |
| 2013 Q3 | 246.53 Million EUR | 36.01% |
| 2013 Q4 | 246.53 Million EUR | 0.0% |
| 2012 Q4 | 243.33 Million EUR | 0.0% |
| 2012 Q1 | 184.39 Million EUR | -2.37% |
| 2012 Q2 | 184.39 Million EUR | 0.0% |
| 2012 Q3 | 243.33 Million EUR | 31.96% |
| 2012 FY | 855.46 Million EUR | 13.23% |
| 2011 Q4 | 188.87 Million EUR | 0.0% |
| 2011 FY | 755.48 Million EUR | 18.61% |
| 2011 Q1 | 159.24 Million EUR | 0.0% |
| 2011 Q2 | 159.24 Million EUR | 0.0% |
| 2011 Q3 | 188.87 Million EUR | 18.61% |
| 2010 FY | 636.96 Million EUR | 28.09% |
| 2010 Q4 | 159.24 Million EUR | 0.0% |
| 2010 Q3 | 159.24 Million EUR | 28.09% |
| 2010 Q2 | 124.31 Million EUR | 0.0% |
| 2010 Q1 | 124.31 Million EUR | 0.0% |
| 2009 Q4 | 124.31 Million EUR | 0.0% |
| 2009 Q2 | 107.94 Million EUR | 0.0% |
| 2009 Q1 | 107.94 Million EUR | 0.0% |
| 2009 FY | 497.26 Million EUR | 15.16% |
| 2009 Q3 | 124.31 Million EUR | 15.16% |
| 2008 FY | 431.78 Million EUR | 0.0% |
| 2008 Q3 | 107.94 Million EUR | 0.0% |
| 2008 Q4 | 107.94 Million EUR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Natural Beauty Bio-Technology Limited | 200.34 Million HKD | -906.419% |
| Innovative Pharmaceutical Biotech Limited | 840 Thousand HKD | -239937.024% |
| China Overseas Nuoxin International Holdings Limited | 35.69 Million HKD | -5549.354% |
| Prosperous Future Holdings Limited | 71.05 Million HKD | -2737.71% |
| Huasheng International Holding Limited | 154.45 Million HKD | -1205.419% |
| Fourace Industries Group Holdings Limited | 95.5 Million HKD | -2011.254% |
| Evergreen Products Group Limited | 233.23 Million HKD | -764.505% |
| EC Healthcare | 704.74 Million HKD | -186.107% |
| Ming Fai International Holdings Limited | 488.74 Million HKD | -312.545% |
| Blue Moon Group Holdings Limited | 4.35 Billion HKD | 53.731% |
| SuperRobotics Holdings Limited | 7.28 Million HKD | -27592.776% |
| Takbo Group Holdings Limited | 75.4 Million HKD | -2573.975% |
| Hyfusin Group Holdings Limited | 335.54 Million HKD | -500.913% |